Fundraising Fox
Prana Therapies
Encinitas, US · Founded 2024 · Delaware corporation
Find your way into Prana Therapies
Sign up to see every warm intro you have to Prana Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prana Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MS
SG
Sheila GujrathiFounder and CEOSheila Gujrathi is an MD with over 25 years in biotech and pharmaceuticals, having previously served as CMO at Receptos (acquired by Celgene), co-founder and CEO of Gossamer Bio, and held leadership roles in immunology at Bristol-Myers Squibb and Genentech; she earned her BS in biomedical engineering and MD from Northwestern University and completed clinical training in internal medicine and allergy/immunology at Brigham and Women's Hospital, Harvard Medical School, UCSF, and Stanford University.
BA
Ben AuspitzNamed on SEC filing
AB
Alexis BorisyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$45.2M disclosed across 2 rounds · 2024–2025
▶$40.2MraisedAug 2026 · 9 investors · BiotechnologyRule 506(b)
▶$40.2MraisedAug 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben AuspitzDirector
- Alexis BorisyDirector
- Sheila Gujrathi, M.D.Executive Officer, Director
- Hector OrtegaExecutive Officer
- Ryan SullivanExecutive Officer
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel SanjuanExecutive Officer, Director
- Sheila GujrathiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Prana Therapies went on to found or lead other companies.
Frequently asked questions
- How much funding has Prana Therapies raised?
- Prana Therapies has disclosed $45.2M raised across 2 rounds.
- Where is Prana Therapies headquartered?
- Prana Therapies is headquartered in Encinitas, US.